NDC 85972-103 – Tacrolimus
Tacrolimus 5 mg/1 · Capsule · Oral
Product NDC85972-103
Product details
- Brand name
- Tacrolimus
- Generic name
- Tacrolimus
- Labeler
- Stellon Biotech Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213112
- Marketed since
- August 7, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Active ingredients
- Tacrolimus 5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 85972-103-01 | 100 CAPSULE in 1 BOTTLE (85972-103-01) | Aug 7, 2025 |
| 85972-103-30 | 30 CAPSULE in 1 BOTTLE (85972-103-30) | Aug 7, 2025 |
Other Tacrolimus products
- 50090-5581 Tacrolimus 1 mg/1 · Capsule · A-S Medication Solutions
- 50090-5596 Tacrolimus 1 mg/1 · Capsule · A-S Medication Solutions
- 16729-041 Tacrolimus .5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-043 Tacrolimus 5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-042 Tacrolimus 1 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-422 Tacrolimus 1 mg/g · Ointment · Accord Healthcare Inc.
- 16729-421 Tacrolimus .3 mg/g · Ointment · Accord Healthcare Inc.
- 82983-402 Tacrolimus 5 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 82983-400 Tacrolimus .5 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 82983-401 Tacrolimus 1 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 68084-450 Tacrolimus 1 mg/1 · Capsule · American Health Packaging
- 68084-449 Tacrolimus .5 mg/1 · Capsule · American Health Packaging